Ventriculoarterial decoupling in human septic shock

Fabio Guarracino, Baldassare Ferro, Andrea Morelli, Pietro Bertini, Rubia Baldassarri, Michael R Pinsky, Fabio Guarracino, Baldassare Ferro, Andrea Morelli, Pietro Bertini, Rubia Baldassarri, Michael R Pinsky

Abstract

Introduction: Septic shock is the most severe manifestation of sepsis. It is characterized as a hypotensive cardiovascular state associated with multiorgan dysfunction and metabolic disturbances. Management of septic shock is targeted at preserving adequate organ perfusion pressure without precipitating pulmonary edema or massive volume overload. Cardiac dysfunction often occurs in septic shock patients and can significantly affect outcomes. One physiologic approach to detect the interaction between the heart and the circulation when both are affected is to examine ventriculoarterial coupling, which is defined by the ratio of arterial elastance (Ea) to left ventricular end-systolic elastance (Ees). In this study, we analyzed ventriculoarterial coupling in a cohort of patients admitted to ICUs who presented with vs without septic shock.

Methods: In this retrospective cross-sectional opportunity study, we measured routine hemodynamics using indwelling arterial and pulmonary arterial catheters and transthoracic echocardiograms in 25 septic patients (group S) and 25 non-septic shock patients (group C) upon ICU admission. Ees was measured by echocardiography using a single-beat (EesSB) method. Ea was calculated as 0.9 systolic arterial pressure/stroke volume, and then the Ea/EesSB ratio was calculated (normal value <1.36).

Results: In group S, 21 patients had an Ea/EesSB ratio >1.36 (uncoupled). The four patients with Ea/EesSB ratios ≤1.36 had higher EesSB values than patients with Ea/EesSB ratios >1.36 (P = 0.007), although Ea measurements were similar in both groups (P = 0.4). In group C, five patients had uncoupled Ea/EesSB ratios. No correlation was found between EesSB and left ventricular ejection fraction and between Ea/EesSB ratio and mixed venous oxygen saturation in septic shock patients.

Conclusions: Upon admission to the ICU, patients in septic shock often display significant ventriculoarterial decoupling that is associated with impaired left ventricular performance. Because Ea/Ees decoupling alters cardiovascular efficiency and cardiac energetic requirements independently of Ea or Ees, we speculate that septic patients with ventriculoarterial uncoupling may benefit from therapy aimed at normalizing the Ea/Ees ratio.

Figures

Figure 1
Figure 1
Pressure–volume relationship in a cardiac cycle. The slope of end-systolic elastance (Ees) (red line) represents the end-systolic pressure–volume relationship. The slope of arterial elastance (Ea) (green line) represents the relation between stroke volume (SV) and left ventricular (LV) systolic pressure as SV is varied.
Figure 2
Figure 2
Left ventricular end-systolic elastance was calculated by using the single-beat method. These echocardiographic scans display the evaluation of ejection fraction (left image) and preejection and ejection time (right image) using aortic Doppler waveforms. Normalized ventricular elastance at arterial end-diastole (End) was measured according to the following formula: Eessb=Pd-ENdest×Ps×0.9/[SV×ENdest]ENdavg=Σai×tNdi=0ENdest=0.0275–0.165×EF+0.3656×Pd/Pes+0.515×ENdavg where ai values are 0.35695, -7.2266, 74.249, -307.39, 684.54. -856.92, 571.95 and -159.1 for i = 1 to i = 7, respectively. The value tNd value was determined by the ratio of pre-ejection period (R-wave to flow onset) to total systolic period (R-wave to end-flow), with the time of onset and termination of flow-defined Doppler. Systolic blood pressure and diastolic blood pressure were measured invasively. The single-beat method used to calculate left ventricular end-systolic elastance was previously validated by Chen et al. [8].
Figure 3
Figure 3
Graphs representing the distribution of ratios of arterial elastance to single-beat end-systolic elastance in newly diagnosed septic shock patients (A) and non–septic shock patients (B).

References

    1. Werdan K, Müller-Werdan U. Elucidating molecular mechanisms of septic cardiomyopathy—the cardiomyocyte model. Mol Cell Biochem. 1996;163–164:291–303.
    1. Flierl MA, Rittirsch D, Huber-Lang MS, Sarma JV, Ward PA. Molecular events in the cardiomyopathy of sepsis. Mol Med. 2008;14:327–336.
    1. Vieillard-Baron A. Septic cardiomyopathy. Ann Intensive Care. 2011;1:6. doi: 10.1186/2110-5820-1-6.
    1. Parker MM, McCarthy KE, Ognibene FP, Parrillo JE. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest. 1990;97:126–131. doi: 10.1378/chest.97.1.126.
    1. Sunagawa K, Maughan WL, Sagawa K. Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res. 1985;56:586–595. doi: 10.1161/01.RES.56.4.586.
    1. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol. 1983;245:H773–H780.
    1. Burkhoff D, Sagawa K. Ventricular efficiency predicted by an analytical model. Am J Physiol. 1986;250:R1021–R1027.
    1. Starling MR. Left ventricular-arterial coupling relations in the normal human heart. Am Heart J. 1993;125:1659–1666. doi: 10.1016/0002-8703(93)90756-Y.
    1. Chantler PD, Lakatta EG, Najjar SS. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. J Appl Physiol. 2008;105:1342–1351. doi: 10.1152/japplphysiol.90600.2008. A published erratum appears in J Appl Physiol 2009, 106:1027.
    1. Hatib F, Jansen JRC, Pinsky MR. Peripheral vascular decoupling in porcine endotoxic shock. J Appl Physiol. 2011;111:853–860. doi: 10.1152/japplphysiol.00066.2011.
    1. Kim HK, Alhammouri MT, Mokhtar YM, Pinsky MR. Estimating left ventricular contractility using inspiratory-hold maneuvers. Intensive Care Med. 2007;33:181–189. doi: 10.1007/s00134-006-0443-8.
    1. Takeuchi M, Igarashi Y, Tomimoto S, Odake M, Hayashi T, Tsukamoto T, Hata K, Takaoka H, Fukuzaki H. Single-beat estimation of the slope of the end-systolic pressure-volume relation in the human left ventricle. Circulation. 1991;83:202–212. doi: 10.1161/01.CIR.83.1.202.
    1. Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PA, Kawaguchi M, Kass DA. Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol. 2001;38:2028–2034. doi: 10.1016/S0735-1097(01)01651-5.
    1. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637. doi: 10.1097/CCM.0b013e31827e83af.
    1. Guarracino F, Baldassarri R, Pinsky MR. Ventriculo-arterial decoupling in acutely altered hemodynamic states. Crit Care. 2013;17:213. doi: 10.1186/cc12522.
    1. Prabhu SD. Altered left ventricular-arterial coupling precedes pump dysfunction in early heart failure. Heart Vessels. 2007;22:170–177. doi: 10.1007/s00380-006-0954-9.
    1. Goto Y, Futaki S, Kawaguchi O, Hata K, Takasago T, Saeki A, Nishioka T, Suga H. Left ventricular contractility and energetic cost in disease models—an approach from the pressure–volume diagram. Jpn Circ J. 1992;56:716–721. doi: 10.1253/jcj.56.716.
    1. Takaoka H, Takeuchi M, Odake M, Hayashi Y, Mori M, Hata K, Yokoyama M. Comparison of the effects on arterial-ventricular coupling between phosphodiesterase inhibitor and dobutamine in the diseased human heart. J Am Coll Cardiol. 1993;22:598–606. doi: 10.1016/0735-1097(93)90071-8.
    1. Guarracino F, Cariello C, Danella A, Doroni L, Lapolla F, Stefani M, Baldassarri R, Vullo C. Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy. Acta Anaesthesiol Scand. 2007;51:1217–1224. doi: 10.1111/j.1399-6576.2007.01428.x.
    1. Ishihara H, Yokota M, Sobue T, Saito H. Relation between ventriculoarterial coupling and myocardial energetics in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1994;23:406–416. doi: 10.1016/0735-1097(94)90428-6.
    1. Beanlands RS, Bach DS, Raylman R, Armstrong WF, Wilson V, Montieth M, Moore CK, Bates E, Schwaiger M. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol. 1993;22:1389–1398. doi: 10.1016/0735-1097(93)90548-F.
    1. Martin RS, Norris PR, Kilgo PD, Miller PR, Hoth JJ, Meredith JW, Chang MC, Morris JA Jr. Validation of stroke work and ventricular arterial coupling as markers of cardiovascular performance during resuscitation. J Trauma. 2006;60:930–935. doi: 10.1097/01.ta.0000217943.72465.52.
    1. Ducrocq N, Kimmoun A, Furmaniuk A, Hekalo Z, Maskali F, Poussier S, Marie PY, Levy B. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction. Anesthesiology. 2012;116:1083–1091. doi: 10.1097/ALN.0b013e31824f9669.

Source: PubMed

3
Abonnieren